Maternal IL-33 critically regulates tissue remodeling and type 2 immune responses in the uterus during early pregnancy in mice.
Maternal IL-33 critically regulates tissue remodeling and type 2 immune responses in the uterus during early pregnancy in mice.
复制标题
DOI:
10.1073/pnas.2123267119
复制
发表时间:
2022-08-30
影响因子:
11.1
通讯作者:
中科院分区:
文献类型:
--
作者:
Recent clinical studies suggest that abnormal interleukin-33 (IL-33) signaling is associated with poor pregnancy outcomes in women, including recurrent pregnancy loss, preeclampsia, and preterm labor. Nevertheless, how IL-33 supports pregnancy progression in mammals is not well understood. Here, we show that pregnant mice lacking the Il33 gene exhibit a broad spectrum of cellular, physiological, and immunological defects that manifest very early in pregnancy. Our data suggest that IL-33 signaling supports diverse, pro-pregnancy processes at the maternal–fetal interface during early gestation, which in turn lay the foundation for optimal outcomes at later stages of pregnancy. Ultimately, our findings have the potential to inform therapeutic applications and interventions that target IL-33 to improve pregnancy outcomes in women. The pregnant uterus is an immunologically rich organ, with dynamic changes in the inflammatory milieu and immune cell function underlying key stages of pregnancy. Recent studies have implicated dysregulated expression of the interleukin-1 (IL-1) family cytokine, IL-33, and its receptor, ST2, in poor pregnancy outcomes in women, including recurrent pregnancy loss, preeclampsia, and preterm labor. How IL-33 supports pregnancy progression in vivo is not well understood. Here, we demonstrate that maternal IL-33 signaling critically regulates uterine tissue remodeling and immune cell function during early pregnancy in mice. IL-33–deficient dams exhibit defects in implantation chamber formation and decidualization, and abnormal vascular remodeling during early pregnancy. These defects coincide with delays in early embryogenesis, increased resorptions, and impaired fetal and placental growth by late pregnancy. At a cellular level, myometrial fibroblasts, and decidual endothelial and stromal cells, are the main IL-33+ cell types in the uterus during decidualization and early placentation, whereas ST2 is expressed by uterine immune populations associated with type 2 immune responses, including ILC2s, Tregs, CD4+ T cells, M2- and cDC2-like myeloid cells, and mast cells. Early pregnancy defects in IL-33–deficient dams are associated with impaired type 2 cytokine responses by uterine lymphocytes and fewer Arginase-1+ macrophages in the uterine microenvironment. Collectively, our data highlight a regulatory network, involving crosstalk between IL-33–producing nonimmune cells and ST2+ immune cells at the maternal–fetal interface, that critically supports pregnancy progression in mice. This work has the potential to advance our understanding of how IL-33 signaling may support optimal pregnancy outcomes in women.
登录
查看更多内容
影响因子:
3.7
作者:
Granne I;Southcombe JH;Snider JV;Tannetta DS;Child T;Redman CW;Sargent IL
通讯作者:
Sargent IL
影响因子:
3.4
作者:
Wang XH;Liu W;Fan DX;Hu WT;Li MQ;Zhu XY;Jin LP
通讯作者:
Jin LP
影响因子:
15.3
作者:
Ashkar, A A;Di Santo, J P;Croy, B A
通讯作者:
Croy, B A
影响因子:
3.4
作者:
Kaitu'u-Lino, Tu'uhevaha J.;Tuohey, Laura;Tong, Stephen
通讯作者:
Tong, Stephen
影响因子:
4.4
作者:
Kurowska-Stolarska, Mariola;Stolarski, Bartosz;Liew, Foo Y.
通讯作者:
Liew, Foo Y.